|
BLZF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.031000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.743200E-01 |
| Normal-vs-Stage2 |
2.319000E-01 |
| Normal-vs-Stage3 |
3.251800E-01 |
| Normal-vs-Stage4 |
1.278560E-01 |
| Stage1-vs-Stage2 |
4.011400E-01 |
| Stage1-vs-Stage3 |
9.343500E-02 |
| Stage1-vs-Stage4 |
4.027600E-02 |
| Stage2-vs-Stage3 |
1.063040E-01 |
| Stage2-vs-Stage4 |
5.926500E-02 |
| Stage3-vs-Stage4 |
6.548400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.312000E-01 |
| Normal-vs-AfricanAmerican |
3.997800E-04 |
| Normal-vs-Asian |
3.900200E-01 |
| Caucasian-vs-AfricanAmerican |
3.8744000000035E-05 |
| Caucasian-vs-Asian |
5.590800E-01 |
| AfricanAmerican-vs-Asian |
3.613200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.154800E-01 |
| Normal-vs-Female |
2.037400E-01 |
| Male-vs-Female |
6.698200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.658200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.829600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.582600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.664400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.683400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.332800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.020000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.776200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.171200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.324800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.571390E-01 |
| Normal-vs-Grade 2 |
5.120100E-02 |
| Normal-vs-Grade 3 |
4.067600E-01 |
| Normal-vs-Grade 4 |
8.923000E-03 |
| Grade 1-vs-Grade 2 |
8.858200E-01 |
| Grade 1-vs-Grade 3 |
2.677600E-01 |
| Grade 1-vs-Grade 4 |
3.866000E-02 |
| Grade 2-vs-Grade 3 |
1.033570E-02 |
| Grade 2-vs-Grade 4 |
1.373620E-04 |
| Grade 3-vs-Grade 4 |
5.650100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.3387999999478E-06 |
| Normal-vs-ccB subtype |
1.551730E-02 |
| ccA subtype-vs-ccB subtype |
6.17879969411206E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.454000E-01 |
| Normal-vs-N1 |
5.858800E-01 |
| N0-vs-N1 |
4.341800E-01 |
|
|
